BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/26/2025 10:27:32 AM | Browse: 67 | Download: 349
 |
Received |
|
2025-08-31 07:57 |
 |
Peer-Review Started |
|
2025-08-31 07:57 |
 |
First Decision by Editorial Office Director |
|
2025-09-04 07:46 |
 |
Return for Revision |
|
2025-09-04 07:46 |
 |
Revised |
|
2025-09-09 22:14 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2025-11-20 02:37 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-11-20 06:40 |
 |
Articles in Press |
|
2025-11-20 06:40 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2025-12-18 02:19 |
 |
Publish the Manuscript Online |
|
2025-12-26 10:27 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Steatotic liver disease in patients with chronic hepatitis C
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jakub Janczura, Michał Brzdęk, Robert Flisiak, Krystyna Dobrowolska, Kinga Brzdęk, Piotr Rzymski and Dorota Zarębska-Michaluk |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Michał Brzdęk, Collegium Medicum, Jan Kochanowski University, aleja IX Wieków Kielc 19A, Kielce 25-516, Poland. michal.brzdek@gmail.com |
| Key Words |
Hepatitis C; Steatotic liver disease; Direct-acting antivirals; Real-world study, hepatitis C virus |
| Core Tip |
Steatotic liver disease (SLD) is common in patients with chronic hepatitis C and shapes their overall health and treatment journey. In our real-world study, SLD patients were older, had higher body mass index, and carried more metabolic and liver-related risks, leading to lower response rates to antiviral therapy. Yet, SLD itself was not the culprit - other comorbidities were. This highlights that successful treatment depends not only on antivirals but also on managing the broader metabolic and lifestyle factors that impact liver health. |
| Publish Date |
2025-12-26 10:27 |
| Citation |
Janczura J, Brzdęk M, Flisiak R, Dobrowolska K, Brzdęk K, Rzymski P, Zarębska-Michaluk D. Steatotic liver disease in patients with chronic hepatitis C. World J Hepatol 2025; 17(12): 113639 |
| URL |
https://www.wjgnet.com/1948-5182/full/v17/i12/113639.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v17.i12.113639 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.